Kev kos duab ntawm peb cov kws tshaj lij hauv peptides, nrog rau peb lub zog R & D platform, peb ntawm Hybio muab cov peptides customized ntawm ntau qhov sib txawv. Cov no yog tsim los siv ob qho tib si-theem thiab cov txheej txheem ua kua-theem kom ua tau raws li kev xav tau ntawm peb cov neeg siv khoom thoob ntiaj teb.
Txog
Hybio Pharmaceutical Co., Ltd.peb kev daws teeb meem
Peb muab rau kojCRO & CDMO
Peb muab ntau yam peptides thoob ntiaj teb, xws li Liraglutide, Semaglutide thiab Exenatide rau ntshav qab zib; Terlipressin, Desmopressin thiab Linaclotide rau digestive ib ntsuj av thiab metabolic system; Ganirelix, Cetrorelix thiab Atosiban rau obstetrics thiab gynecology, thiab lwm yam.
Peb qhov ADVANTAGE
Peb qhov kev sib tw tseem ceebNyob rau hauv 2011, Hybio tau teev nyob rau hauv Shenzhen Tshuag Txauv Kev Lag Luam (Tshuag code 300199), thiab tau los ua thawj lub lag luam ntawm kev tsim tshuaj peptide hauv Suav teb.
Saib ntxiv-
US FDA Pom Zoo
API site/FDF site/R&D site
-
200+
Muab rau 200+ cov tuam txhab tshuaj
-
160+
Pab pawg R & D ntawm 160+
-
30+ APIs
Portfolio suav nrog 30+ APIs
-
10+ cGMP
10+ cGMP kev pom zoo tau txais los ntawm cov koom haum tswj hwm thoob ntiaj teb GMP
-
20+ DMFs
20+ DMFs tau ua ntaub ntawv hauv ntau lub tebchaws
-
100+ lub teb chaws
Muaj nyob hauv 100+ lub teb chaws suav nrog Asmeskas, Europe & lwm lub ntiaj teb
-
5
5 Cov chaw ua haujlwm zoo tshaj plaws
-
410
410+ Patents Tau txais